BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20734335)

  • 1. Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.
    Trainor PA
    Am J Med Genet A; 2010 Dec; 152A(12):2984-94. PubMed ID: 20734335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.
    Terrazas K; Dixon J; Trainor PA; Dixon MJ
    Wiley Interdiscip Rev Dev Biol; 2017 May; 6(3):. PubMed ID: 28186364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treacher Collins syndrome: etiology, pathogenesis and prevention.
    Trainor PA; Dixon J; Dixon MJ
    Eur J Hum Genet; 2009 Mar; 17(3):275-83. PubMed ID: 19107148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial dysostoses: Etiology, pathogenesis and management.
    Trainor PA; Andrews BT
    Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):283-94. PubMed ID: 24123981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniofacial malformations: intrinsic vs extrinsic neural crest cell defects in Treacher Collins and 22q11 deletion syndromes.
    Walker MB; Trainor PA
    Clin Genet; 2006 Jun; 69(6):471-9. PubMed ID: 16712696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
    Sakai D; Trainor PA
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal craniofacial development: new insights on normal and abnormal mechanisms.
    Johnston MC; Bronsky PT
    Crit Rev Oral Biol Med; 1995; 6(4):368-422. PubMed ID: 8664424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
    Noack Watt KE; Achilleos A; Neben CL; Merrill AE; Trainor PA
    PLoS Genet; 2016 Jul; 12(7):e1006187. PubMed ID: 27448281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.
    Sakai D; Trainor PA
    Dev Growth Differ; 2016 Sep; 58(7):577-85. PubMed ID: 27481486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
    Sakai D; Dixon J; Achilleos A; Dixon M; Trainor PA
    Nat Commun; 2016 Jan; 7():10328. PubMed ID: 26792133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of the Treacher Collins syndrome (mandibulofacial dysostosis).
    Poswillo D
    Br J Oral Surg; 1975 Jul; 13(1):1-26. PubMed ID: 807232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranial Neural Crest Cells and Their Role in the Pathogenesis of Craniofacial Anomalies and Coronal Craniosynostosis.
    Siismets EM; Hatch NE
    J Dev Biol; 2020 Sep; 8(3):. PubMed ID: 32916911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of polr1c in Early Embryogenesis Rescues the Type 3 Treacher Collins Syndrome Facial Malformation Phenotype in Zebrafish.
    Kwong EML; Ho JCH; Lau MCC; You MS; Jiang YJ; Tse WKF
    Am J Pathol; 2018 Feb; 188(2):336-342. PubMed ID: 29128566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sf3b4-depleted Xenopus embryos: A model to study the pathogenesis of craniofacial defects in Nager syndrome.
    Devotta A; Juraver-Geslin H; Gonzalez JA; Hong CS; Saint-Jeannet JP
    Dev Biol; 2016 Jul; 415(2):371-382. PubMed ID: 26874011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of POLR1C-dependent Type 3 Treacher Collins Syndrome revealed by a zebrafish model.
    Lau MC; Kwong EM; Lai KP; Li JW; Ho JC; Chan TF; Wong CK; Jiang YJ; Tse WK
    Biochim Biophys Acta; 2016 Jun; 1862(6):1147-58. PubMed ID: 26972049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal craniofacial development: new insights on normal and abnormal mechanisms.
    Johnston MC; Bronsky PT
    Crit Rev Oral Biol Med; 1995; 6(1):25-79. PubMed ID: 7632866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
    Jones NC; Lynn ML; Gaudenz K; Sakai D; Aoto K; Rey JP; Glynn EF; Ellington L; Du C; Dixon J; Dixon MJ; Trainor PA
    Nat Med; 2008 Feb; 14(2):125-33. PubMed ID: 18246078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome.
    van Gijn DR; Tucker AS; Cobourne MT
    Br J Oral Maxillofac Surg; 2013 Jul; 51(5):384-8. PubMed ID: 23036831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dental anomalies, ectopic eruption and associated oral malformations in subjects with Treacher Collins syndrome.
    da Silva Dalben G; Costa B; Gomide MR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):588-92. PubMed ID: 16632269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniofacial morphology in Treacher Collins syndrome.
    Arvystas M; Shprintzen RJ
    Cleft Palate Craniofac J; 1991 Apr; 28(2):226-30; discussion 230-1. PubMed ID: 2069981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.